The early Phase 2 clinical study of JTS-653 in Post-Herpetic Neuralgia

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221142

Enrollment

160

Registered

2010-06-30

Start date

2010-06-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Herpetic Neuralgia

Interventions

investigational material(s) Generic name etc : JTS-653 INN of investigational material : Therapeutic category code : 129 Other agents affecting peripheral nervous system Dosage and Administration for

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient who passed for 3 months or more after the herpes zoster onset.

Exclusion criteria

Exclusion criteria: The patient who has other chronic pains in the PHN affected part

Design outcomes

Primary

Measure	Time frame
Visual analog scale	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026